buprenorphine hydrochloride
Generic: buprenorphine hydrochloride
Labeler: hikma pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
buprenorphine hydrochloride
Generic Name
buprenorphine hydrochloride
Labeler
hikma pharmaceuticals usa inc.
Dosage Form
INJECTION
Routes
Active Ingredients
buprenorphine hydrochloride .324 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0143-9246
Product ID
0143-9246_8ba9787c-d429-4a5d-8424-e13be15cb9f1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076931
DEA Schedule
ciii
Listing Expiration
2026-12-31
Marketing Start
2005-05-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01439246
Hyphenated Format
0143-9246
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
buprenorphine hydrochloride (source: ndc)
Generic Name
buprenorphine hydrochloride (source: ndc)
Application Number
ANDA076931 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .324 mg/mL
Packaging
- 5 VIAL in 1 CARTON (0143-9246-05) / 1 mL in 1 VIAL (0143-9246-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "8ba9787c-d429-4a5d-8424-e13be15cb9f1", "openfda": {"unii": ["56W8MW3EN1"], "rxcui": ["238129"], "spl_set_id": ["adc1167e-910e-4d7b-abdc-751d3df0c3dc"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL in 1 CARTON (0143-9246-05) / 1 mL in 1 VIAL (0143-9246-01)", "package_ndc": "0143-9246-05", "marketing_start_date": "20190712"}], "brand_name": "Buprenorphine Hydrochloride", "product_id": "0143-9246_8ba9787c-d429-4a5d-8424-e13be15cb9f1", "dosage_form": "INJECTION", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "0143-9246", "dea_schedule": "CIII", "generic_name": "Buprenorphine Hydrochloride", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine Hydrochloride", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": ".324 mg/mL"}], "application_number": "ANDA076931", "marketing_category": "ANDA", "marketing_start_date": "20050525", "listing_expiration_date": "20261231"}